SCHEMBL6292940

SCHEMBL6292940

COc1ccc(CCN[C]=O)cc1OC

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.65
POLB P06746 1/20 0.65
CA2 P00918 3/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
CA12 O43570 2/20 0.59
CA1 P00915 2/20 0.59
CA9 Q16790 2/20 0.59
CA5A P35218 1/20 0.59
CA14 Q9ULX7 1/20 0.59
MAPT P10636 1/20 0.58
KMT2A Q03164 1/20 0.56
KDM4E B2RXH2 2/20 0.54
HTT P42858 1/20 0.54
ALDH1A1 P00352 2/20 0.52
GLA P06280 1/20 0.52
LMNA P02545 1/20 0.52
TSHR P16473 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1486249 0.83 ALDH1A1 (0.60) ATMPOLBCA2SMN1; SMN2CA1
SCHEMBL8518764 0.82 POLB (0.63) ATMPOLBCA2SMN1; SMN2CA12
SCHEMBL10501189 0.81 CA12 (0.58) CA2CA12CA1CA9CA14
SCHEMBL7435099 0.80 ATM (0.76) ATMPOLBCA2SMN1; SMN2CA12
Hydrochloric Acid SCHEMBL11808765 0.79 ATM (0.73) ATMPOLBCA2SMN1; SMN2CA12
SCHEMBL8635081 0.79 ATM (1.00) ATMPOLBCA2SMN1; SMN2CA12
SCHEMBL30230461 0.79 ATM (1.00) ATMPOLBCA2SMN1; SMN2CA12
SCHEMBL557799 0.79 ATM (1.00) ATMPOLBCA2SMN1; SMN2CA12
SCHEMBL7265002 0.79 CA12 (0.73) ATMPOLBCA2SMN1; SMN2CA12
SCHEMBL31157848 0.78 CYP19A1 (0.77) ATMPOLBCA2MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4716162-A BRAIN FUNCTION SANKYO COMPANY, LIMITED (JP) 1987-12-29 US claimed
US-6867200-B1 (Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2005-03-15 US disclosed
EP-0171217-B1 FUSED-RING HETEROCYCLIC COMPOUNDS A PROCESS FOR THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE SANKYO COMPANY LIMITED (JP) 1989-05-03 EP disclosed
US-4716162-A BRAIN FUNCTION SANKYO COMPANY, LIMITED (JP) 1987-12-29 US disclosed
EP-0171217-A2 Fused-ring heterocyclic compounds a process for their production and their pharmaceutical use SANKYO COMPANY LIMITED (JP) 1986-02-12 EP disclosed
US-4209622-A 3-(Ethoxycarbonyl-methyl)-6-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine Chinoin Gygyszer es Vegyeszeti Termekek Gyara Rt. (HU) 1980-06-24 US disclosed